Dec 16, 2019: FedEx Express’ TNT Life Science Center in Japan has expanded its capacity with ultra-modern facilities to respond to the needs and requirements of healthcare clients for clinical trial logistics servicing both domestic as well as international markets to Japan.
The upgradation at the Life Science Center includes 80 percent increase in clinical drug storage capacity and the new facility will now stand at 3500 square meters. The chiller rooms and ambient rooms have been expanded with separate temperature zones (between 2 degrees to 8 degrees Celsius and 20 degrees Celsius). An allocation room has been set where investigational medication product and placebos would be assigned inside the facility. Furthermore, all three rooms would be equipped with humidity control. A frozen storage unit has been created to enable storage of between minus 20 degrees and minus 30 degrees Celsius. A centralized monitoring system will ensure temperature and humidity integrity and controlling of all temperature-controlled facilities. The security systems have been enhanced with earthquake resistance standards compliance and renovation of the private back-up power generation system.
Overseas pharmaceutical customers can now ship investigational medication product in bulk to the Life Science Center in Tokyo, which will store them in temperature-controlled facilities, instead of shipping individually when needed. The drugs can then be delivered to hospitals all over Japan when needed in special temperature-controlled packaging systems. After the trial ends, the unused drugs can be retrieved from the hospitals and stored in the Life Science Center for return to the origin or destruction. The upgraded Life Science Center – an important hub for storage and transportation of investigational medication product in Japan – will continue to meet the diverse needs of global pharmaceutical companies and contract research organizations (CROs). It will help customers simplify the clinical trial logistics and optimize cost and time efficiencies, so they can focus on more important business priorities.
The pharmaceutical industry is moving to combat rare diseases with more advances in research. Japan is the second fastest growing mature pharmaceutical market in the world, close behind the U.S. and expecting dramatic rise in generics and biosimilars in 2020. This will drive demand for stable supply of investigational medication product to support development, and better clinical trial logistics solutions.
“Asia Pacific is fast gaining preference from pharma companies the world over as a key destination for conducting clinical trials given the large patient pool and cost efficiencies. FedEx Express plays a key role as a strategic differentiator for success in clinical trial logistics, especially for potentially life-changing complex shipments,” said Karen Reddington, president, Asia Pacific, FedEx Express. “With FedEx healthcare solutions, our customers have the benefit of deep healthcare logistics expertise, supplemented by global networks so they can stay compliant with global import and export regulations along with the assurance that their shipments will be transported under best-in-class facilities.”